✦ LIBER ✦

Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer

✍ Scribed by Rajeshkumar, N.V.; Tan, A. C.; De Oliveira, E.; Womack, C.; Wombwell, H.; Morgan, S.; Warren, M. V.; Walker, J.; Green, T. P.; Jimeno, A.; Messersmith, W. A.; Hidalgo, M.

Book ID: 117989643
Publisher: American Association for Cancer Research
Year: 2009
Tongue: English
Weight: 728 KB
Volume: 15
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-08-3021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFECT OF THE SPECIFIC SRC KINASE INHIBI

EFFECT OF THE SPECIFIC SRC KINASE INHIBITOR AZD0530 ON OSTEOLYTIC LESIONS IN PROSTATE CANCER

✍ Yang, Joy C; Bai, Lanfang; Kung, Hsing-Jien; Evans, Christopher P 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB

361 Preclinical activity of AZD0530, a n

361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases

✍ T.P. Green; M. Fennell; R. Whittaker; J. Curwen; V. Jacobs; J. Allen; P.A. Ple; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

617 POSTER In vivo evaluation of efficac

617 POSTER In vivo evaluation of efficacy and pharmacodynamic biomarkers of AZD0530, a dual-specific Src/Abl kinase inhibitor, in preclinical, subcutaneous xenograft models

✍ A. Logié; V. Jacobs; M. Fennell; J. Hargreaves; R. Westwood; N. Haupt; P. Elvin; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 159 KB

391 POSTER A Phase I randomized trial to

391 POSTER A Phase I randomized trial to assess the effects of Src inhibitor AZD0530 on renal function in healthy volunteers

✍ R. Chetty; N. Dalton; M. Rimmer; N. Cockburn; I. Smith; A. Swaisland; J. Hargrea 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Effects of the Src kinase inhibitor sara

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

✍ Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 243 KB

962 CLUSTERIN KNOCKDOWN ENHANCES ANTITUM

962 CLUSTERIN KNOCKDOWN ENHANCES ANTITUMOR ACTIVITY OF A NOVEL AKT INHIBITOR, AZD5363, THROUGH INHIBITION OF AUTOPHAGY IN PROSTATE CANCER

✍ Kumano, Masafumi; Zhang, Fan; Shiota, Masaki; Crafter, Claire; Davies, Barry; Zo 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 156 KB